07-11-2025 16:14 via drugs.com

GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide

FRIDAY, Nov. 7, 2025-- For patients with type 2 diabetes (T2D), the gastrointestinal safety profile is similar for dulaglutide, semaglutide, and tirzepatide, according to a study published online Nov. 4 in the Annals of Internal Medicine.Salvatore...
Read more »

Pharmaceutical Industry news



Guidelines Expanded for Cervical Cancer Screening to Include Self-Swab HPV Test
Rocatinlimab Yields Significant Improvements in Atopic Dermatitis
Immediate Neuro-Rehabilitative Therapy After TBI Cuts Alzheimer Disease Risk
Polyphenol-Rich Foods Tied to Better Cardiovascular Health
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval
Medical Professionals Lack Knowledge on Health Implications of Adoption
Home Hospital Care Beneficial for Acute Illness in Rural Settings
AES: First Seizure Clinic Speeds Time to Diagnosis With Pediatric Epilepsy
RSNA: Long-Term Exposure to Air Pollution Linked to More Advanced CAD
Inaugural Report Describes Trends in Pediatric Cancer in U.S.
Corticosteroids Probably Cut Short-Term Mortality in Severe Pneumonia, ARDS
Poorer Nutritional Outcomes Seen for Older Adults Who Eat Alone
Oral Engasertib Safe for Hereditary Hemorrhagic Telangiectasia
Appropriate Duration of ADT in Prostate Cancer Depends on Risk
Desktop versie